// App-Quantinova.ai

: IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma

Researchers

Presenter

  • James Pinkerton

Principal Investigators

  • Richard Kim

  • Alexandra Brown

  • Brittany Rae

  • Jemma Mayall

  • Md.Khadem Ali

  • Malcolm Starkey

  • Avril Robertson

  • Lisa Wood

  • Matthew Cooper

  • Luke ONeill

  • Philip Hansbro

  • Jay Horvat

Medical Centers

  • NCRI, London, United Kingdom

  • 2, Newcastle, Australia

  • QIMR, Brisbane, Australia

  • MMUH, Dublin, Ireland

  • RNSH, Sydney, Australia

Locations

  • United Kingdom

  • Australia

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Obesity

  • Asthma

Biomarkers

  • Interleukin 13

  • Interleukin 5

  • NLR family pyrin domain containing 3

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A